Nasus Pharma is trading 7.33% higher at $3.73 in after-hours trading, with no confirmed catalyst.
- It closed at $3.53 on September 4, 2026.
- No new company-specific announcement dated September 4 was identified; the latest company release found was the August 19 CFO transition announcement.
- The S&P 500 fell 0.45% and Nasdaq fell 0.29%.